Drugs / Exparel Forearm block
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02058303 Background | Feb 2014 → Mar 2016 | — | Jose Soberon, MD | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exparel Forearm block | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02058303 ↗ |
| Route | Other | “20-30 mL Mepivacaine will be used for the supraclavicular block following the forearm block.” NCT02058303 ↗ |